Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

2(33.3%)

N/A

2(33.3%)

Phase 1

1(16.7%)

Phase 3

1(16.7%)

6Total

Phase 4(2)

N/A(2)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT02533544Completed

Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B

Role: collaborator

NCT03683485Not ApplicableUnknown

Long-duration EPBD vs EST for Removal of Biliary Stones

Role: collaborator

NCT01654601Phase 1Completed

A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg

Role: collaborator

NCT01554007Unknown

Clinical Course of Korean Crohn's Disease Cohort

Role: collaborator

NCT02308891Not ApplicableCompleted

A Prospective Trial of Aggressive Hydration Strategy to Reduce Post-ERCP Pancreatitis

Role: collaborator

NCT01505855Phase 4Completed

Efficacy Study of Pneumococcal Vaccination in Crohn's Disease

Role: collaborator

NCT00414505Phase 3Unknown

A Randomized Controlled Double Blinding Study of Intradermal Acupuncture Treatment on Obesity

Role: lead

NCT01903902Phase 4Unknown

Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries

Role: collaborator

All 8 trials loaded